Autohome Inc. (NYSE:ATHM) recently saw its volume around 0.96 million shares and on average it trades 0.77 million shares a day. The opening price of $75.33, led it to gain 5.31% to reach $78.33 upon the closing bell.Autohome Inc. (ATHM) Analyst Opinion
Autohome Inc. has a consensus outperform rating from 10 Wall Street analysts, and the number of shares currently sold short amount to at least 1.74% of shares outstanding. The stock spiked 1.87% last month and is up 22.42 this year. Wall Street is only getting more bullish on the stock, with 8 of analysts who cover ATHM having a buy-equivalent rating. Analysts have placed a $69.03 price target on Autohome Inc., suggesting a -11.87% decline from recent close. It’s currently trading about -9.82% below its 52-week high.
Autohome Inc. (ATHM) surprised the stock market in its last reported earnings when it earned $0.6 a piece versus the consensus-estimated $0.56. Its revenue totaled $226.3 million down -2.86% from the previous quarter.Autohome Inc. (NYSE:ATHM) Intraday View
This stock (ATHM) is ahead of its 52-week low with 176.53%. Its last month’s stock price volatility remained 6.34% which for the week stands at 4.34%. The share price has moved backward from its 20 days moving average, trading at a distance of -2.37% and stays 11.2% away from its 50 days moving average. Over the last five days, shares have managed 4.01% gains and now is up 37.11% since hitting its 200-day moving average of $64.34. Autohome Inc. (ATHM) has made its way to a 12-month gain of 132.24%.
Turning to Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), its shares were trading at $10.13 a gain of $0.5, on the trading floor. The stock, after opening at $9.65, touched a high of $10.3 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Syros Pharmaceuticals, Inc. has 2 buy ratings, 2 holds and 0 sells even after the stock tumbled -58.44% from its high of $24.38 to a $274.62 million market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 2 to 2 during a month. Analysts set a 12-month price target of $21 a share. The target implies a 107.31% spike from where the shares are currently trading. Also, the current price highlights a discount of 225.77% to analysts’ high consensus price target.Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Intraday Trading
The counter witnessed a trading volume of 0.28 million shares versus an average volume of 0.4 million shares during last trading session. Its last month’s stock price volatility remained 9.44% which for the week approaches 6.72%. The lowest price the stock reached in the last trading day was $9.42 and compares with the $6.30 52-week low. The stock recovered 60.79% since its low point and has performed 4.11% year-to-date.